Orexigen, Duke, Eisai Strike Foreign IP Deal
Orexigen Therapeutics Inc., Duke University and Eisai Co Ltd. on Wednesday agreed to a settlement that resolves all foreign aspects of a lawsuit related to the use of zonisamide to treat...To view the full article, register now.
Already a subscriber? Click here to view full article